Carbapenems are broad spectrum coverage antibiotics against both gram positive and gram negative bacteria and is β-lactamase resistant. The drugs are “antibiotics of last resort”, so as not to encourage development of resistance bacteria. Thus in clinical practice, carbapenems are often reserved for use when there are multi-drug resistant pathogens or polymicrobial infections. Carbapenem drugs are administered intravenously in hospitals.
Savior Lifetec Corporation’s (SLC) specialization in this niche product class enables SLC to maintain a global leadership position. SLC currently has product registrations in over 80 countries: